Research Topics
| Allan H RopperSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trialAllan H Ropper
Department of Neurology, Brigham and Women s Hospital, Boston, MA 02115, USA
Ann Neurol 65:386-93. 2009..Randomized, blinded trial of intramuscular gene transfer using plasmid vascular endothelial growth factor (VEGF) to treat diabetic polyneuropathy...
Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case reportGregory L Cvetanovich
Department of Neurology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
J Med Case Reports 5:548. 2011..abstract:..- Paraneoplastic limbic encephalitis presenting as a neurological emergency: a case reportZongqi Xia
Department of Neurology, Brigham and Women s Hospital, Boston, MA, USA
J Med Case Reports 4:95. 2010..Paraneoplastic limbic encephalitis remains a challenging clinical diagnosis with poor outcome if it is not recognized and treated early in the course of the disease... 
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGFRudolf Kirchmair
Department of Cardiovascular Research, St Elizabeth s Medical Center Tufts University School of Medicine, Boston, Massachusetts, USA
Mol Ther 15:69-75. 2007..These findings implicate microvascular damage as the basis for toxic neuropathy and suggest that angiogenic growth factors may constitute a novel treatment for this disorder...- Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathyKenneth C Gorson
Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
Neurology 63:715-7. 2004..The authors found that MMF induced a modest benefit in ~20% of their patients and stabilized patient condition, allowing reduction of steroid or IVIg therapy... - Influence of critical illness on axonal loss in Guillain-Barré syndromeDoreen Ho
Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
Muscle Nerve 39:10-5. 2009..11), in the ICU (26 vs. 15), and in the hospital (29 vs. 18). Sixty-eight percent of patients with GBS in the ICU developed axon loss, but this was not related to the usual precipitants of CIP... - Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trialKenneth C Gorson
Department of Neurology, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts 02135, USA
Muscle Nerve 35:66-9. 2007..There was no improvement in secondary endpoints. No adverse events occurred. In this small prospective study, rituximab did not reduce IVIg requirements in the majority of patients with IVIg-dependent, immune-mediated polyneuropathies... - The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndromeRashmi Sanjay
Department of Medicine, Hematology and Transfusion Medicine Section, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
J Clin Apher 21:105-10. 2006..Therapeutic plasma exchange need not be extended when plasma fibrinogen remains > or =30% below its level at presentation by the time of the final planned plasma exchange procedure... - Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growthRudolf Kirchmair
Division of Cardiovascular Research, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
Circulation 111:2662-70. 2005..The pathogenic basis for toxic neuropathies induced by chemotherapeutic agents has not been completely elucidated... - Current treatments for CIDPAllan H Ropper
Saint Elizabeth s Medical Center Tufts University School of Medicine, Boston, MA, USA
Neurology 60:S16-22. 2003..Research is needed to find agents suitable for single and combination therapy in CIDP... - Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathyKenneth C Gorson
Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge St, Boston, MA 02135, USA
Arch Neurol 59:766-72. 2002..Plasma exchange has been shown to be effective but alternative therapies have not been systematically evaluated... - Clinical practice. ConcussionAllan H Ropper
Department of Neurology, Caritas St. Elizabeth's Medical Center, and Tufts University School of Medicine, Boston, MA 02135, USA
N Engl J Med 356:166-72. 2007 - Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implicationsKenneth C Gorson
Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts 02135, USA
Muscle Nerve 28:553-60. 2003..ataxic neuropathy is uncommon; and (4). the lack of sicca symptoms or anti-SSA or SSB antibodies in patients with neuropathy does not exclude Sjögren syndrome based upon salivary gland pathology...